We performed GO enrichment and KEGG pathway analyses, which showed that activity of HE compounds were associated with various neurochemical processes that are dysregulated in depression, including MAPK, IL-17, TNF and neurotrophin signalling. The gene discussed is BDNF; the disease is depressive disorder.